Cancer Attributable to Infection?

06/08/2022

Dr. Edward B. Breitschwerdt,

Bartonella spp. are stealth bacterial pathogens. A One Health approach to this emerging infection is defining disease manifestations, establishing the comparative disease pathogenesis for these bacterial pathogens, providing insights into effective treatment regimens, and elucidating strategies to prevent zoonotic disease transmission from animals to humans. 

Dogs and humans develop nearly identical types of pathology when infected with a Bartonella spp. As such, defining the role of these bacteria in dogs with hemangiosarcoma may provide important comparative oncology lessons for veterinary and human medicine. In this presentation Dr. Breitschwerdt will discuss Bartonella spp. and what we know about the relationship between infection with this bacteria and hemangiosarcoma in dogs. Discussion will include:

  • Bartonella lesions that occur in dogs and humans

  • The mechanisms by which bacteria might cause cancer

  • The potential sources of Bartonella spp. exposures and modes of organism transmission to dogs

  • The mechanisms by which Bartonella spp. may contribute to the development of hemangiosarcoma

  • The benefits and limitations of serological, molecular and enrichment culture tests for the diagnosis of bartonellosis in dogs with hemangiosarcoma

Original publication date June 8, 2022
Presented by Edward B. Breitschwerdt, DVM, DACVIM

Click here to register

Learn more about Dr. Breitschwerdt's CHF-funded research:

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

   2020 GuideStar logo

© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.